Home › Exclusive- India's Lupin, U.S. firms weigh bids for GSK's mature drugs: sources
 

Keywords :   


Exclusive- India's Lupin, U.S. firms weigh bids for GSK's mature drugs: sources

2014-07-22 22:02:47| Biotech - Topix.net

Assuming a multiple of between two and three times those sales, the assets on the block could fetch between $3.5 billion and $5.0 billion , the sources said.

Tags: sources exclusive drugs firms

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
17.05Fewer crackers in Ritz boxes but price remains same
17.05Eastern North Pacific Tropical Weather Outlook
17.05Boeing boss's $33m pay package approved
17.05Heifers and female cows remain hot topic at sale barn
17.05Dutch Boy Paints Introduces Professional Series at Menards
17.05Atlantic Tropical Weather Outlook
17.05RadTech 2024 Sustainability Award Winners are Selected
17.05BYK-Gardner USA Launches New Dispermat Dissolver CV3evo
More »